Yona Levites

Yona Levites

Department of Neuroscience, University of Florida

Affiliated withUniversity of Florida

Research Area

Biography

Yona Levites has not added Biography.
If you are Yona Levites and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Publication title

Cited by 262

2014

Other Publications

Article
Year
Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kappaB) activation and cell death by tea extracts in neuronal cultures.

Biochemical pharmacology| PubMed ID: 11754870

2002
2002
Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 12670874

2003
2002
2003
2006
2006
Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 17068112

2006
2006
Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 17611268

2007
BRI2 (ITM2b) inhibits Abeta deposition in vivo.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 18524908

2008
Quantitative and mechanistic studies of Abeta immunotherapy.

CNS & neurological disorders drug targets| PubMed ID: 19275635

2009
Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19638957

2009
Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 19825975

2010
2011
2012
2012
2012
2013
2013
2013
2013